Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study - Concepedia

Concepedia

Publication | Closed Access

Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study

73

Citations

47

References

2005

Year

John D. Lloyd‐Still, Catherine A. Powers, Dennis R. Hoffman, Katherine Boyd-Trull, Lucille A. Lester, Diane C. Benisek, Linda M. Arterburn

High DoseCystic Fibrosis PatientsPharmacologyToxicologyAlgal OriginMedicine

References

	Year	Citations

Page 1